These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
☐
|
Preliminary Proxy Statement
|
|
|
|
|
☐
|
Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
|
|
ý
|
Definitive Proxy Statement
|
|
|
|
|
☐
|
Definitive Additional Materials
|
|
|
|
|
☐
|
Soliciting Material under §240.14a-12
|
|
ý
|
No fee required.
|
|
|
|
|
|
|
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
|
5)
|
Total fee paid:
|
|
|
|
|
|
☐
|
Fee paid previously with preliminary materials:
|
|
|
|
|
|
|
☐
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.
|
|
|
|
|
|
|
|
1)
|
Amount previously paid:
|
|
|
2)
|
Form, Schedule or Registration Statement No.:
|
|
|
3)
|
Filing Party:
|
|
|
4)
|
Date Filed:
|
|
|
||||
|
(1)
|
The election of seven directors to serve on the Company’s board of directors until the Company’s 2019 annual meeting of stockholders and until their respective successors are duly elected and qualify;
|
|
(2)
|
The ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018;
|
|
(3)
|
A non-binding advisory vote on our executive compensation; and
|
|
(4)
|
The transaction of such other business as may properly come before the Annual Meeting or any postponements or adjournments thereof.
|
|
By Order of the Board,
|
|
|
|
/s/ Jeffrey W. Eckel
|
|
Jeffrey W. Eckel
|
|
President and Chief Executive Officer
|
|
•
|
for the election of a director, a plurality of all the votes cast in the election of directors at the Annual Meeting,
|
|
•
|
for the ratification of the appointment of our independent registered public accounting firm, a majority of all the votes cast on the proposal and
|
|
•
|
for the approval of the non-binding advisory resolution to approve the compensation of the Named Executive Officers, a majority of all the votes cast on the proposal.
|
|
|
For the Year Ended December 31, 2017
|
|
For the Year Ended December 31, 2016
|
||||
|
|
(in thousands)
|
||||||
|
Audit fees
(1)
|
$
|
2,349
|
|
|
$
|
1,777
|
|
|
Audit-related fees
(2)
|
222
|
|
|
59
|
|
||
|
Tax fees
(3)
|
243
|
|
|
120
|
|
||
|
Total
|
$
|
2,814
|
|
|
$
|
1,956
|
|
|
(1)
|
Audit fees include fees and expenses related to the annual audit of the financial statements of the Company and its subsidiaries and our internal controls over financial reporting, the review of the consolidated financial statements included in our quarterly reports on Form 10-Q and for services associated with our public offerings, including review of the registration statement and related issuances of comfort letters and consents and other services related to SEC matters.
|
|
(2)
|
Audit-related fees include fees and expenses related to agreed-upon procedures performed on certain of our securitization transactions.
|
|
(3)
|
Tax fees include fees and expenses related to tax compliance and tax return preparation services, as well as tax planning and advisory services.
|
|
•
|
aligning our management team’s interests with stockholders’ expectations;
|
|
•
|
motivating and rewarding our management team to grow our assets and earnings in a manner that is consistent with prudent risk-taking and based on sound corporate governance practices; and
|
|
•
|
attracting and retaining an experienced and effective management team while also maintaining an appropriate expense structure.
|
|
(1)
|
Core earnings is not a financial measure calculated in accordance with GAAP. A reconciliation of core earnings to GAAP net income is located on page 73 of our Form 10-K for the year ended December 31, 2017, filed with the SEC on February 23, 2018.
|
|
(2)
|
Net interest margin is not a financial measure calculated in accordance with GAAP. It is calculated as interest income plus rental income plus core equity method investments earnings plus amortization of intangibles, less interest expense. Core equity method investments earnings and amortization of intangibles are located on page 73 of our Form 10-K for the year ended December 31, 2017. The other amounts are located on page 87 of our Form 10-K for the year ended December 31, 2017. Our Form 10-K for the year ended December 31, 2017, was filed with the SEC on February 23, 2018.
|
|
(3)
|
The efficiency ratio is not a financial measure calculated in accordance with GAAP. A lower efficiency ratio indicates a more efficient use of compensation and general and administrative expenses to generate revenue. It is calculated as compensation and benefits expense plus general and administrative expense, divided by total revenue plus core equity method investments earnings and amortization of intangibles. Compensation and benefits expense, general and administrative expense and total revenue are located on page 87 of our Form 10-K for the year ended December 31, 2017. Core equity method investments
|
|
•
|
Closed approximately $1 billion of transactions for the year
|
|
•
|
Delivered 78% annual GAAP EPS growth and 6% annual Core EPS growth in 2017
|
|
•
|
Over $2.5 billion widely diversified pipeline.
|
|
•
|
Over 25% annual growth in our balance sheet to approximately $2.3 billion, diversified across approximately 175 separate investments
|
|
•
|
Achieved a fixed-rate debt level of 92% as of December 31, 2017, up from 67% last year
|
|
•
|
An estimated 530,000 metric tons of annual CO2 equivalent emissions or carbon emissions will be offset by our 2017 transactions equating to a CarbonCount® score of 0.56, or 0.56 metric tons per $1,000 invested. Additionally, we achieved zero Scope 1 and Scope 2 carbon emissions from the operations of our business. For additional details related to these carbon emissions standards, see “Corporate Governance and Social and Responsibility—Environmental Impact”.
|
|
Name
|
|
Fees Paid or Earned in Cash ($)
|
|
Stock Awards ($)
(1)
|
|
Total
($)
|
|
Rebecca B. Blalock
|
|
35,208
|
|
64,991
|
|
100,199
|
|
Teresa M. Brenner
|
|
77,500
|
|
64,991
|
|
142,491
|
|
Mark J. Cirilli
|
|
80,000
|
|
64,991
|
|
144,991
|
|
Charles M. O’Neil
|
|
73,125
|
|
64,991
|
|
138,116
|
|
Richard J. Osborne
|
|
90,000
|
|
64,991
|
|
154,991
|
|
Steven G. Osgood
|
|
85,000
|
|
64,991
|
|
149,991
|
|
(1)
|
Each of Messrs. Cirilli, O’Neil, Osgood and Osborne, and Mses. Blalock and Brenner were granted 3,426 shares of restricted Common Stock in 2017 valued at $18.97 per share, the closing price of our Common Stock on the NYSE at the date of grant. The shares of Common Stock granted in 2017 vest on March 5, 2019. As of December 31, 2017, each of Messrs. Cirilli, O’Neil and Osborne held 6,887 shares of unvested restricted Common Stock, Mr. Osgood held 8,627 shares of unvested restricted Common Stock, Ms. Brenner held 6,959 shares of unvested restricted Common Stock and Ms. Blalock held 3,426 shares of unvested restricted Common Stock.
|
|
•
|
cash retainer of $65,000 annually per director.
|
|
•
|
cash retainer to the Chair of the Audit Committee of $20,000 annually.
|
|
•
|
cash retainer to the Lead Independent Director of $25,000 annually.
|
|
•
|
cash retainer to each of the Chairs of the Compensation Committee, the Nominating, Governance and Corporate Responsibility Committee and the Finance and Risk Committee of $15,000 annually.
|
|
•
|
our board of directors is not staggered, with each of our directors subject to re-election annually;
|
|
•
|
our board of directors has determined that six of our seven directors are independent for purposes of the NYSE corporate governance listing standards and Rule 10A-3 under the Exchange Act;
|
|
•
|
two of our directors each qualify as an “
audit committee financial expert
” as defined by the SEC;
|
|
•
|
two of our directors are women, constituting 29% of the board, in furtherance of our board diversity policy;
|
|
•
|
our Guidelines provide for a majority vote policy for the election of directors pursuant to which any nominee who receives a greater number of votes “withheld” from his or her election than votes “for” such election shall promptly tender his or her resignation to our board of directors, which shall consider whether or not to accept such resignation, as described in greater detail below;
|
|
•
|
we have established a target retirement age of 75 for our directors;
|
|
•
|
we have an active stockholder outreach program;
|
|
•
|
we have amended and restated our Statement of Corporate Policy Regarding Equity Transaction in 2017 to prohibit our directors and officers from hedging equity securities of the Company, holding such securities in a margin account or pledging such securities as collateral for a loan;
|
|
•
|
In 2017, we adopted a Clawback Policy which provides for the possible recoupment of performance or incentive-based compensation in the event of an accounting restatement due to material noncompliance by the Company with any financial reporting requirements under the securities laws (other than due to a change in applicable accounting methods, rules or interpretations);
|
|
•
|
we have opted out of the control share acquisition statute in the Maryland General Corporations Law (the “
MGCL
”) and have exempted from the business combinations statute in the MGCL transactions that are approved by our board of directors;
|
|
•
|
we do not have a stockholder rights plan; and
|
|
•
|
we have expanded the role of our Nominating, Governance and Corporate Responsibility Committee to also focus on directing the strategy and oversight of our ESG strategies, activities, policies and communications.
|
|
Name
|
|
Age
|
|
Jeffrey W. Eckel
|
|
59
|
|
J. Brendan Herron
|
|
57
|
|
Nathaniel J. Rose
|
|
40
|
|
Steven L. Chuslo
|
|
60
|
|
Daniel K. McMahon
|
|
46
|
|
M. Rhem Wooten Jr.
(1)
|
|
58
|
|
•
|
aligning our management team’s interests with those of our stockholders;
|
|
•
|
motivating and rewarding our management team for executing our operational plans with a focus on sustainable long-term growth in a manner that is consistent with appropriate risk-taking based on sound corporate governance practices; and
|
|
•
|
attracting and retaining an experienced and effective management team while also maintaining an appropriate expense structure.
|
|
•
|
base salary, which is an element of compensation set at levels that are commensurate with our NEOs positions and provide fixed pay to attract and retain our NEOs, taking into account our budgeted operating expenses;
|
|
•
|
incentive compensation (annual bonus) that is payable in cash or equity that vests over a period of time from date of grant and is based on achievement of certain quantitative and qualitative corporate and individual performance objectives; and
|
|
•
|
long-term equity incentive program comprised of awards subject to both time-based and performance-based vesting that are designed to meet both our long-term growth and retention objectives.
|
|
|
|
Percentage of 2017 Targeted Compensation
|
|
|
Compensation Element
|
Type of Compensation
|
Mr. Eckel
|
Other Named
Executive Officers |
|
Annual base salary
|
Fixed
|
14%
|
18% to 23%
|
|
Annual cash or equity incentive
|
Variable / Equity-based
|
20%
|
22% to 28%
|
|
Long-term equity incentive program
|
Variable / Equity-based
|
66%
|
49% to 60%
|
|
(1)
|
Core earnings is not a financial measure calculated in accordance with GAAP. A reconciliation of core earnings to GAAP net income is located on page 73 of our Form 10-K for the year ended December 31, 2017, filed with the SEC on February 23, 2018.
|
|
(2)
|
Net interest margin is not a financial measure calculated in accordance with GAAP. It is calculated as total interest income plus rental income plus core equity method investments earnings plus amortization of intangibles, less interest expense. Core equity method investments earnings and amortization of intangibles are located on page 73 of our Form 10-K for the year ended December 31, 2017. The other amounts are located on page 87 of our Form 10-K for the year ended December 31, 2017. Our Form 10-K for the year ended December 31, 2017, was filed with the SEC on February 23, 2018.
|
|
(3)
|
The efficiency ratio is not a financial measure calculated in accordance with GAAP. A lower efficiency ratio indicates a more efficient use of compensation and general and administrative expenses to generate revenue. It is calculated as compensation and benefits expense plus general and administrative expense, divided by total revenue plus core equity method investments earnings and amortization of intangibles. Compensation and benefits expense, general and administrative expense and total revenue are located on page 87of our Form 10-K for the year ended December 31, 2017. Core equity method investments earnings and amortization of intangibles are located on page 73 of our Form 10-K for the year ended December 31, 2017. Our Form 10-K for the year ended December 31, 2017, was filed with the SEC on February 23, 2018.
|
|
•
|
Compensation Committee comprised solely of independent directors.
|
|
•
|
Independent compensation consultant that is engaged directly by the Compensation Committee and provides no other services to management or the Company.
|
|
•
|
Compensation structure with targeted compensation that is predominately variable and equity-based.
|
|
•
|
Compensation Committee reviewed and considered total compensation for each NEO against a peer group (as defined below).
|
|
•
|
Robust stock ownership guidelines.
|
|
•
|
Recoupment policy for performance or incentive-based compensation in the event of an accounting restatement due to material noncompliance by the Company with any financial reporting requirements under the securities laws.
|
|
•
|
Limited executive perquisites.
|
|
•
|
Hedging, pledging and margin accounts related to our Common Stock not permitted by any of our NEOs.
|
|
•
|
Equity incentive plan that prohibits repricing of stock options without prior stockholder approval.
|
|
•
|
Equity incentive plan provides that equity awards are subject to a minimum vesting period of no less than one year.
|
|
Arbor Realty Trust, Inc.
|
New York Mortgage Trust, Inc.
|
|
|
|
|
Capstead Mortgage Corporation
|
NewStar Financial, Inc.
|
|
|
|
|
CYS Investments, Inc.
|
Pattern Energy Group Inc.
|
|
|
|
|
Hercules Capital, Inc.
|
PHH Corporation
|
|
|
|
|
HFF, Inc.
|
Redwood Trust, Inc.
|
|
|
|
|
iStar Inc.
|
Triangle Capital Corporation
|
|
|
|
|
Ladder Capital Corp.
|
Walker & Dunlop, Inc.
|
|
|
|
|
Main Street Capital Corporation
|
|
|
|
|
|
|
Compensation Element
|
Objective
|
Key Features
|
|
|
|
|
|
Base Salary
|
• Provides a fixed element of compensation commensurate with each NEOs position and responsibility.
|
• Adjustments are generally considered annually based on individual performance, level of pay relative to the market and our peer group, internal pay equity, and retention issues.
|
|
|
|
|
|
Annual Incentive Compensation (Cash and Equity)
|
• Provides an annual cash incentive or bonus based upon our overall corporate and individual performance as well as objective and subjective performance criteria that are aligned with the strategic direction of the Company.
|
• Compensation Committee approves the overall corporate and individual performance measures as well as objective and subjective performance criteria on an annual basis.
• Compensation Committee determines allocation between cash and stock on an annual basis, as well as the vesting criteria of the annual equity awards.
|
|
|
|
|
|
Long-term incentive program
|
• Provides equity-based incentives in the form of restricted stock or RSUs or other equity awards that contain multi- year vesting and/or performance criteria in order to further our retention objectives and align the interests of our NEOs with those of our stockholders over a longer time period.
|
• Compensation Committee determines allocation between time-based and performance-based awards.
• Compensation Committee determines the performance targets and vesting criteria.
|
|
|
|
|
|
Health Welfare, and Other Benefits
|
• Offers all eligible employees a competitive benefits package, which includes health and welfare benefits, such as 401(k), medical, dental, disability insurance, and life insurance benefits
|
• The plans under which these benefits are offered do not discriminate in scope, terms or operation in favor of officers and are available to all eligible employees.
|
|
|
|
|
|
Perquisites and Other Benefits
|
• Currently do not provide any perquisites and do not intend to provide perquisites exceeding $15,000 in the aggregate to our NEOs because we believe that we can provide better incentives for desired performance with compensation in the forms described above.
|
• N/A
|
|
Name
|
|
2016 Annual
Salary ($) |
|
2017 Annual
Salary ($) |
|
2018 Annual
Salary ($) |
|
Jeffrey W. Eckel
|
|
619,500
|
|
619,500
|
|
639,500
|
|
J. Brendan Herron
|
|
360,000
|
|
360,000
|
|
380,000
|
|
Nathaniel J. Rose
|
|
327,500
|
|
343,875
|
|
363,875
|
|
Steven L. Chuslo
|
|
355,000
|
|
355,000
|
|
360,000
|
|
Daniel K. McMahon
|
|
322,000
|
|
322,000
|
|
342,000
|
|
M. Rhem Wooten Jr.
|
|
343,500
|
|
343,500
|
|
343,500
|
|
Name
|
|
2016 and 2017
Target Bonus (%) |
|
2016 Actual
Bonus (%) |
|
2017 Actual
Bonus (%) |
|
Jeffrey W. Eckel
|
|
150
|
|
140
|
|
114
|
|
J. Brendan Herron
|
|
125
|
|
118
|
|
101
|
|
Nathaniel J. Rose
|
|
125
|
|
118
|
|
101
|
|
Steven L. Chuslo
|
|
125
|
|
118
|
|
101
|
|
Daniel K. McMahon
|
|
125
|
|
118
|
|
101
|
|
M. Rhem Wooten Jr.
|
|
125
|
|
118
|
|
101
|
|
Corporate Performance Objectives
|
|
Weighting
|
|
Quantitative Company
Performance Hurdle (1) |
|
Payout as a % of Target Upon Achievement of Hurdle
(1)
|
|
Actual
Performance |
|
2016 annual core earnings / share
(2)
|
|
50%
|
|
$1.15 – $1.21
|
|
50%
|
|
|
|
|
|
|
|
$1.21
|
|
100%
|
|
$1.20
|
|
|
|
|
|
$1.21 – $1.27
|
|
150%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Origination volume
(3)
|
|
15%
|
|
$1.0 billion
|
|
50%
|
|
|
|
|
|
|
|
$1.1 billion
|
|
100%
|
|
$1.1 billion
|
|
|
|
|
|
$1.2 billion
|
|
150%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net credit losses, as % of total assets
(4)
|
|
15%
|
|
<0.11%
|
|
100%
|
|
0.0%
|
|
|
|
|
|
|
|
|
|
|
|
Execution of the finance plan
|
|
10%
|
|
Target
|
|
100%
|
|
100%
|
|
|
|
|
|
|
|
|
|
|
|
Sarbanes-Oxley readiness
|
|
10%
|
|
Target
|
|
100%
|
|
100%
|
|
(1)
|
Actual results were pro-rated between the values, with exception of the net credit losses, execution of the finance plan and readiness under the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”).
|
|
(2)
|
Core earnings is not a financial measure calculated in accordance with GAAP. A reconciliation of core earnings to GAAP net income is located on pages 72-74 of our Form 10-K for the year ended December 31, 2016, filed with the SEC on February 24, 2017.
|
|
(3)
|
Origination volume is the dollar volume of transactions completed in a year as disclosed on page 6 of our Form 10-K for the year ended December 31, 2016, filed with the SEC on February 24, 2017.
|
|
(4)
|
Net credit losses is the dollar amount of any provision for credit losses as disclosed on page 74 of our Form 10-K for the year ended December 31, 2016, filed with the SEC on February 24, 2017.
|
|
Name
|
|
Total Incentive
Compensation Earned in 2016 ($) |
|
% of
Incentive Compensation Paid in Cash |
|
% of Incentive
Compensation Paid in Restricted Stock (1) |
|
Jeffrey W. Eckel
|
|
864,891
|
|
35
|
|
65
|
|
J. Brendan Herron
|
|
425,108
|
|
35
|
|
65
|
|
Nathaniel J. Rose
|
|
386,201
|
|
35
|
|
65
|
|
Steven L. Chuslo
|
|
419,276
|
|
35
|
|
65
|
|
Daniel K. McMahon
|
|
379,989
|
|
35
|
|
65
|
|
M. Rhem Wooten Jr.
|
|
405,474
|
|
35
|
|
65
|
|
(1)
|
Shares of restricted Common Stock issued as part of the annual incentive compensation are issued from our Equity Incentive Plan, valued $18.97 per share, the closing price of our Common Stock on the NYSE on the date of grant, and vest in March 2019.
|
|
Corporate Performance Objectives
|
|
Weighting
|
|
Quantitative Company
Performance Hurdle (1) |
|
Payout as a % of Target Upon Achievement of Hurdle
(1)
|
|
Actual
Performance |
|
2017 annual core earnings / share
(2)
|
|
60%
|
|
$1.25 – $1.32
|
|
50%
|
|
|
|
|
|
|
|
$1.32
|
|
100%
|
|
$1.27
|
|
|
|
|
|
$1.32 – $1.39
|
|
150%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net interest margin (dollars in millions)
(3)
|
|
15%
|
|
$68.2 - $71.75
|
|
50%
|
|
|
|
|
|
|
|
$71.75
|
|
100%
|
|
$61.3
|
|
|
|
|
|
$71.75-$75.3
|
|
150%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Efficiency ratio
(4)
|
|
15%
|
|
21%
|
|
50%
|
|
|
|
|
|
|
|
20%
|
|
100%
|
|
20%
|
|
|
|
|
|
19%
|
|
150%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net credit losses, as % of total assets
(5)
|
|
10%
|
|
<0.11%
|
|
100%
|
|
0.0%
|
|
(1)
|
Actual results were pro-rated between the values below, with exception of the net credit losses.
|
|
(2)
|
Core earnings is not a financial measure calculated in accordance with GAAP. A reconciliation of core earnings to GAAP net income is located on page 73 of our Form 10-K for the year ended December 31, 2017, filed with the SEC on February 23, 2018.
|
|
(3)
|
Net interest margin is not a financial measure calculated in accordance with GAAP. It is calculated as total interest income plus rental income plus core equity method investments earnings plus amortization of intangibles, less interest expense. Core equity method investments earnings and amortization of intangibles are located on page 73 of our Form 10-K for the year ended December 31, 2017. The other amounts are located on page 87 of our Form 10-K for the year ended December 31, 2017. Our Form 10-K for the year ended December 31, 2017, was filed with the SEC on February 23, 2018.
|
|
(4)
|
The efficiency ratio is not a financial measure calculated in accordance with GAAP. A lower efficiency ratio indicates a more efficient use of compensation and general and administrative expenses to generate revenue. It is calculated as compensation and benefits expense plus general and administrative expense, divided by total revenue plus core equity method investments earnings and amortization of intangibles. Compensation and benefits expense, general and administrative expense and total revenue are located on page 87of our Form 10-K for the year ended December 31, 2017. Core equity method investments earnings and amortization of intangibles are located on page 73 of our Form 10-K for the year ended December 31, 2017. Our Form 10-K for the year ended December 31, 2017 was filed with the SEC on February 23, 2018.
|
|
(5)
|
Net credit losses is the dollar amount of any provision for credit losses as disclosed on page 87 of our Form 10-K for the year ended December 31, 2017, filed with the SEC on February 23, 2018. We realized no credit losses in 2017.
|
|
Name
|
|
Total Incentive
Compensation Earned in 2017 ($) |
|
% of
Incentive Compensation Paid in Cash |
|
% of Incentive
Compensation Paid in Restricted Stock (1) |
|
Jeffrey W. Eckel
|
|
707,624
|
|
-
|
|
100
|
|
J. Brendan Herron
|
|
363,816
|
|
-
|
|
100
|
|
Nathaniel J. Rose
|
|
347,515
|
|
-
|
|
100
|
|
Steven L. Chuslo
|
|
358,752
|
|
-
|
|
100
|
|
Daniel K. McMahon
|
|
325,405
|
|
-
|
|
100
|
|
M. Rhem Wooten Jr.
|
|
347,133
|
|
-
|
|
100
|
|
(1)
|
Shares of restricted Common Stock issued as part of the annual incentive compensation are issued from our Equity Incentive Plan, valued at $19.11 per share, the closing price of our Common Stock on the NYSE on the date of grant, and vest in May 2019.
|
|
Name
|
|
2017 Performance
Based Award Units (1) |
|
2017 Time Based Award Shares
(2)
|
|
Total Value of 2017 Award ($)
(3)
|
|
2018 Performance Based Award Units
(4)
|
|
2018 Time Based Award Shares
(5)
|
|
Total Value of 2018 Award ($)
(6)
|
|
Jeffrey W. Eckel
|
|
94,740
|
|
63,160
|
|
2,997,258
|
|
62,100
|
|
62,100
|
|
2,443,635
|
|
J. Brendan Herron
|
|
31,620
|
|
31,620
|
|
1,200,295
|
|
25,876
|
|
25,874
|
|
1,018,182
|
|
Nathaniel J. Rose
|
|
22,750
|
|
22,750
|
|
863,590
|
|
18,976
|
|
18,974
|
|
746,667
|
|
Steven L. Chuslo
|
|
20,500
|
|
20,500
|
|
778,180
|
|
16,388
|
|
16,387
|
|
644,849
|
|
Daniel K. McMahon
|
|
19,500
|
|
19,500
|
|
740,220
|
|
16,388
|
|
16,387
|
|
644,849
|
|
M. Rhem Wooten Jr.
(7)
|
|
19,500
|
|
19,500
|
|
740,220
|
|
-
|
|
-
|
|
-
|
|
(1)
|
Represents the total amount of RSUs that have been granted, assuming target performance. 50% of the units are to be earned based on Absolute TSR over a three-year time period and 50% of the RSUs are to be earned based on Relative TSR over the same time period. The actual shares of Common Stock to be earned are calculated according to the chart below.
|
|
2017 Award: Total Stockholder Return Metrics
|
|
Threshold
50% |
|
Target
100% |
|
Outperform
200% |
|
Absolute TSR
|
|
25.5%
|
|
31.5%
|
|
39.0%
|
|
Relative TSR
|
|
30.0%
|
|
55.0%
|
|
80.0%
|
|
(2)
|
Represents time-based restricted stock shares that vest in three equal annual amounts on March 15, 2018 and March 5, 2019 and 2020.
|
|
(3)
|
Amounts in this column represent the aggregate grant date fair value of awards of both the time-vested and performance-vested restricted shares of Common Stock computed in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 718 and the assumptions and methodologies set forth in our Annual Report on Form 10-K for the year ended December 31, 2017 (Note 2 and Note 11, Equity). The time vested grants were valued at $18.97 per share, the closing price of our Common Stock on the NYSE on the date of grant. The Absolute TSR RSUs were valued at $15.22 per unit and the Relative TSR RSUs were valued at $22.76, in each case by an independent appraisal.
|
|
(4)
|
Represents the total amount of RSUs that have been granted, assuming target performance. 50% of the units are to be earned based on Absolute TSR over a three-year time period and 50% of the RSUs are to be earned based on Relative TSR over the same time period. The actual shares of Common Stock to be earned are calculated according to the chart below.
|
|
2018 Award: Total Stockholder Return Metrics
|
|
Threshold
50% |
|
Target
100% |
|
Outperform
200% |
|
Absolute TSR
|
|
18.0%
|
|
24.0%
|
|
30.0%
|
|
Relative TSR
|
|
30.0%
|
|
55.0%
|
|
80.0%
|
|
(5)
|
Represents time-based restricted stock shares that vest in three equal annual amounts on May 15, 2019, and March 5, 2020 and 2021.
|
|
(6)
|
Amounts in this column represent the aggregate grant date fair value of awards of both the time-vested and performance-vested restricted shares of Common Stock computed in accordance with FASB ASC Topic 718 and the assumptions and methodologies set forth in our Annual Report on Form 10-K for the year ended December 31, 2017 (Note 2 and Note 11, Equity). The time vested grants were valued at $19.11 per share, the closing price of our Common Stock on the NYSE on the date of grant. The Absolute TSR RSUs were valued at $17.43 per unit and the Relative TSR RSUs were valued at $23.05, in each case by an independent appraisal.
|
|
(7)
|
Mr. Wooten retired from the Company effective April 2018.
|
|
Name and Principal Position
|
|
Year
|
|
Salary ($)
(1)
|
|
Stock
Awards ($) (2) |
|
Non-equity
incentive plan compensation ($) (3) |
|
All other compensation ($)
(4)
|
|
Total ($)
|
|
|
Jeffrey W. Eckel, Director, President and Chief Executive Officer
|
|
2017
|
|
619,500
|
|
3,559,149
|
|
—
|
|
|
20,575
|
|
4,199,224
|
|
|
2016
|
|
594,500
|
|
3,783,550
|
|
303,000
|
|
|
21,331
|
|
4,702,381
|
|
|
|
2015
|
|
528,000
|
|
4,084,968
|
|
—
|
|
|
21,381
|
|
4,634,349
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
J. Brendan Herron, Executive Vice President and Chief Financial Officer
|
|
2017
|
|
360,000
|
|
1,476,404
|
|
—
|
|
|
13,500
|
|
1,849,904
|
|
|
2016
|
|
350,000
|
|
1,405,138
|
|
149,000
|
|
|
13,250
|
|
1,917,388
|
|
|
|
2015
|
|
318,333
|
|
1,123,741
|
|
—
|
|
|
13,250
|
|
1,455,324
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nathaniel J. Rose, Executive Vice President and Chief Investment Officer
|
|
2017
|
|
338,417
|
|
1,114,791
|
|
—
|
|
|
13,500
|
|
1,466,708
|
|
|
2016
|
|
319,167
|
|
1,024,919
|
|
135,000
|
|
|
13,250
|
|
1,492,336
|
|
|
|
2015
|
|
293,333
|
|
841,109
|
|
—
|
|
|
13,250
|
|
1,147,692
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Steven L. Chuslo, Executive Vice President and General Counsel
|
|
2017
|
|
355,000
|
|
1,050,456
|
|
—
|
|
|
13,500
|
|
1,418,956
|
|
|
2016
|
|
346,667
|
|
1,048,600
|
|
147,000
|
|
|
13,250
|
|
1,555,517
|
|
|
|
2015
|
|
320,000
|
|
941,389
|
|
—
|
|
|
13,250
|
|
1,274,639
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Daniel K. McMahon, Executive Vice President
|
|
2017
|
|
322,000
|
|
987,209
|
|
—
|
|
|
13,500
|
|
1,322,709
|
|
|
2016
|
|
313,667
|
|
1,015,622
|
|
133,000
|
|
|
13,250
|
|
1,475,539
|
|
|
|
2015
|
|
288,000
|
|
835,667
|
|
—
|
|
|
13,250
|
|
1,136,917
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M. Rhem Wooten Jr., Executive Vice President
|
|
2017
|
|
343,500
|
|
1,003,694
|
|
—
|
|
|
13,500
|
|
1,360,694
|
|
|
2016
|
|
333,500
|
|
1,049,239
|
|
142,000
|
|
|
13,250
|
|
1,537,989
|
|
|
|
2015
|
|
304,000
|
|
929,321
|
|
—
|
|
|
13,250
|
|
1,246,571
|
|
|
(1)
|
See “—Compensation Discussion and Analysis—Base Salary” for further salary information.
|
|
(2)
|
Amounts in this column represent the aggregate grant date fair value of awards of restricted shares of Common Stock or RSUs computed in accordance with FASB ASC Topic 718. The grant date fair values of awards have been determined based on the assumptions and methodologies set forth in our Annual Report on Form 10-K for the year ended December 31, 2017 (Note 11, Equity). See Equity Incentive Plan and Grants of Plan-Based Awards below for additional information on share grants.
|
|
(3)
|
See “—Compensation Discussion and Analysis—Annual Incentive Compensation—2016 Bonus Awards awarded in 2017” for further information on the non-equity incentive plan compensation earned for 2016 and paid in 2017. There was no non-equity incentive compensation earned in 2017 and paid in 2018.
|
|
(4)
|
Other compensation includes the Company’s matching contribution to each NEO’s 401(k) plan of $13,500 for 2017 and $13,250 for 2016 and 2015 and $7,075, $8,081, $8,131 for 2017, 2016 and 2015, respectively, of key man life insurance for Mr. Eckel, approximately 60% of which is for the benefit of the Company.
|
|
|
|
|
|
Estimated future payouts under
non-equity incentive plan awards |
|
Estimated future payouts
under equity incentive plan awards |
|
All other stock awards: number of shares of stock or units (#)
(2)
|
|
Grant date fair value of stock and option awards ($)
(3)
|
||||||||||||
|
Name and Principal Position
|
|
Grant
Date |
|
Threshold
($) |
|
Target
($) |
|
Maximum
($) |
|
Threshold
($) (1) |
|
Target
($) (1) |
|
Maximum ($)
(1)
|
|
|||||||
|
Jeffrey W. Eckel, Director, President and Chief Executive Officer
|
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
29,620
|
|
|
561,891
|
|
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
63,160
|
|
|
1,198,145
|
|
|
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
47,370
|
|
|
94,740
|
|
|
189,480
|
|
|
—
|
|
|
1,799,113
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
J. Brendan Herron, Executive Vice President and Chief Financial Officer
|
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14,555
|
|
|
276,108
|
|
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
31,620
|
|
|
599,831
|
|
|
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
15,810
|
|
|
31,620
|
|
|
63,240
|
|
|
—
|
|
|
600,464
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Nathaniel J. Rose, Executive Vice President and Chief Investment Officer
|
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13,242
|
|
|
251,201
|
|
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
22,750
|
|
|
431,568
|
|
|
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
11,375
|
|
|
22,750
|
|
|
45,500
|
|
|
—
|
|
|
432,023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Steven L. Chuslo, Executive Vice President and General Counsel
|
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14,353
|
|
|
272,276
|
|
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
20,500
|
|
|
388,885
|
|
|
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
10,250
|
|
|
20,500
|
|
|
41,000
|
|
|
—
|
|
|
389,295
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Daniel K. McMahon, Executive Vice
President |
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13,020
|
|
|
246,989
|
|
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
19,500
|
|
|
369,915
|
|
|
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
9,750
|
|
|
19,500
|
|
|
39,000
|
|
|
—
|
|
|
370,305
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
M. Rhem Wooten Jr., Executive Vice
President |
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13,889
|
|
|
263,474
|
|
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
19,500
|
|
|
369,915
|
|
|
|
3/15/2017
|
|
—
|
|
—
|
|
—
|
|
9,750
|
|
|
19,500
|
|
|
39,000
|
|
|
—
|
|
|
370,305
|
|
|
(1)
|
Represents shares that could be earned under awards of RSUs, which vest based on the achievement of certain targets. See “CD&A—Long-Term Incentive Program Granted in 2017 and 2018” above.
|
|
(2)
|
The awards represent restricted stock granted under our Equity Incentive Plan. The first award for each NEO was granted for the 2016 annual incentive compensation under our Equity Incentive Plan, and vests in March 2019. The second award for each NEO was granted for the 2017 Long-Term Incentive program under our Equity Incentive Plan. A description of the terms for the second award for each NEO of the restricted stock appears at “CD&A—Long-Term Incentive Program Granted in 2017 and 2018” above.
|
|
(3)
|
Amounts shown in this column represent the estimated grant date fair value calculated in accordance with FASB ASC Topic 718 of shares of restricted Common Stock and RSUs under our Equity Incentive Plan. A description of the terms and grant date fair value for the first award for each NEO appears at “CD&A-2016 Bonus Awards awarded in 2017.” A description of the terms and the grant fair value for the second and third award for each NEO of the restricted stock appears at “CD&A—Long-Term Incentive Program Granted in 2017 and 2018” above.
|
|
•
|
an annual base salary no less than those listed in “CD&A—Base Salaries” above, subject to increases at the discretion of our board of directors or the Compensation Committee,
|
|
•
|
eligibility for annual cash performance bonuses based on the satisfaction of performance goals established by our board of directors or the Compensation Committee, which will be awarded at the discretion of the Compensation Committee,
|
|
•
|
participation in our long-term incentive program, as well as other incentive, savings and retirement plans applicable generally to our senior executives,
|
|
•
|
medical and other group welfare plan coverage and fringe benefits provided to our senior executives, and
|
|
•
|
for Mr. Eckel only, payment of the premiums for a long-term disability insurance policy which provide benefits equal to at least 300% of his annual base salary.
|
|
•
|
accrued but unpaid base salary, bonus and other benefits earned and accrued but unpaid prior to the date of termination,
|
|
•
|
an amount equal to the sum of the executive’s then-current annual base salary plus the greater of his annual average bonus over the prior three years (or such fewer years with respect to which the executive received an annual bonus) and the executive’s target annual bonus for the year of termination, multiplied by three for Mr. Eckel, by two for each of Messrs. Herron, Chuslo and Wooten, and by 1.5 for each of Messrs. Rose and McMahon,
|
|
•
|
for Mr. Eckel only, a prorated annual bonus based on the maximum annual bonus that the executive could have earned for the year of termination and the number of days employed in the year of termination,
|
|
•
|
health benefits for the executive and his eligible family members for two years following the executive’s termination of employment at the same level as in effect immediately preceding such termination, subject to reduction to the extent that the executive receives comparable benefits from a subsequent employer, and
|
|
•
|
100% of the unvested stock or stock-based awards held by the executive will become fully vested and/or exercisable.
|
|
•
|
accrued but unpaid base salary, bonus and other benefits earned and accrued but unpaid prior to the date of termination,
|
|
•
|
for Mr. Eckel upon death or disability, and for Messrs. Herron, Rose, Chuslo, McMahon and Wooten, upon death only, his prorated annual bonus for the year in which the termination occurs,
|
|
•
|
for Messrs. Herron, Rose, Chuslo, McMahon and Wooten, upon disability only, the target annual bonus for the year in which the termination occurs,
|
|
•
|
health benefits for the executive and/or his eligible family members for two years following the executive’s termination of employment at the same level as in effect immediately preceding executive’s death or disability, and
|
|
•
|
for Mr. Eckel for all awards, and for Messrs. Herron, Rose, Chuslo, McMahon and Wooten, for certain awards based upon the terms of the applicable grant agreement, 100% of the unvested stock awards held by the executive will become fully vested and/or exercisable. For Messrs. Herron, Rose, Chuslo, McMahon and Wooten, if an award agreement does not otherwise provide for 100% vesting, all other outstanding unvested stock awards, if any, held by the executive, a prorated portion (based on the number of days until death or disability, as applicable, over 365) of any stock that would have vested for the year of the executive’s death or disability, as applicable, will become vested and/or exercisable and any remaining portion of such awards will be forfeited.
|
|
•
|
other than through adjustment as provided in our Equity Incentive Plan, increase the total number of shares of Common Stock reserved for issuance under our Equity Incentive Plan;
|
|
•
|
materially expand the class of directors, officers, employees, consultants and advisors eligible to participate in our Equity Incentive Plan;
|
|
•
|
reprice any stock options under our Equity Incentive Plan; or
|
|
•
|
otherwise require such approval.
|
|
|
|
Option Awards
|
|
Stock Awards
|
||||||||||
|
Name
|
|
Number of Securities Underlying Unexercised Options (#) (Exercisable)
|
|
Number of Securities Underlying Unexercised Options (#) (Unexercisable)
|
|
Equity Incentive
Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#)
|
|
Option Exercise Price ($)
|
|
Option Expiration Date
|
|
Equity Incentive Plan Awards: Number of Shares or Units of Common Stock That Have Not Vested (#)
(1)
|
|
Equity
Incentive Plan Awards: Market Value of Shares or Units of Common Stock That Have Not Vested ($)
(2)
|
|
Jeffrey W. Eckel
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
663,987
|
|
15,975,527
|
|
J. Brendan Herron
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
223,806
|
|
5,384,772
|
|
Nathaniel J. Rose
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
165,744
|
|
3,987,801
|
|
Steven L. Chuslo
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
161,366
|
|
3,882,466
|
|
Daniel K. McMahon
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
155,277
|
|
3,735,965
|
|
M. Rhem Wooten Jr.
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
157,936
|
|
3,799,940
|
|
(1)
|
The following chart summarizes the vesting of the awards by NEO:
|
|
Name and Principal Position
|
|
Shares
|
|
Vesting
|
|
Jeffrey W. Eckel, Director, President and Chief Executive Officer
|
|
168,134
|
|
See Note 3
|
|
|
|
33,333
|
|
3/5/2018
|
|
|
|
180,260
|
|
See Note 4
|
|
|
|
29,620
|
|
3/5/2019
|
|
|
|
63,160
|
|
See Note 5
|
|
|
|
189,480
|
|
See Note 6
|
|
J. Brendan Herron, Executive Vice President and Chief Financial Officer
|
|
56,044
|
|
See Note 3
|
|
|
|
18,777
|
|
3/5/2018
|
|
|
|
39,570
|
|
See Note 4
|
|
|
|
14,555
|
|
3/5/2019
|
|
|
|
31,620
|
|
See Note 5
|
|
|
|
63,240
|
|
See Note 6
|
|
Nathaniel J. Rose, Executive Vice President and Chief Investment Officer
|
|
37,363
|
|
See Note 3
|
|
|
|
17,212
|
|
3/5/2018
|
|
|
|
29,677
|
|
See Note 4
|
|
|
|
13,242
|
|
3/5/2019
|
|
|
|
22,750
|
|
See Note 5
|
|
|
|
45,500
|
|
See Note 6
|
|
Steven L. Chuslo, Executive Vice President and General Counsel
|
|
37,363
|
|
See Note 3
|
|
|
|
18,473
|
|
3/5/2018
|
|
|
|
29,677
|
|
See Note 4
|
|
|
|
14,353
|
|
3/5/2019
|
|
|
|
20,500
|
|
See Note 5
|
|
|
|
41,000
|
|
See Note 6
|
|
Daniel K. McMahon, Executive Vice President
|
|
37,363
|
|
See Note 3
|
|
|
|
16,717
|
|
3/5/2018
|
|
|
|
29,677
|
|
See Note 4
|
|
|
|
13,020
|
|
3/5/2019
|
|
|
|
19,500
|
|
See Note 5
|
|
|
|
39,000
|
|
See Note 6
|
|
M. Rhem Wooten Jr., Executive Vice President
(7)
|
|
37,363
|
|
See Note 3
|
|
|
|
18,507
|
|
3/5/2018
|
|
|
|
29,677
|
|
See Note 4
|
|
|
|
13,889
|
|
3/5/2019
|
|
|
|
19,500
|
|
See Note 5
|
|
|
|
39,000
|
|
See Note 6
|
|
(2)
|
Valued at $24.06, our closing price on the NYSE on December 29, 2017, the last day of trading for 2017.
|
|
(3)
|
These awards consist of two components: (i) 67% of the shares are considered performance-based awards that vest upon the later of March 5, 2019 and the achievement of dividend and earnings growth targets over a multi-year period or achievement of the earnings target for two quarters and (ii) 33% of the shares are time-based awards that vest on March 5, 2019. The specific targets have not been publicly disclosed for competitive reasons but require continued growth in core earnings.
|
|
(4)
|
These awards are performance-based awards that vest upon the achievement of targets over a multi-year period. The specific targets have not been publicly disclosed for competitive reasons but require continued growth in our dividend.
|
|
(5)
|
These awards are time-based awards that vest in three equal annual amounts on March 15, 2018 and March 5, 2019 and 2020.
|
|
(6)
|
These awards are RSUs that represent the right to receive up to two shares per RSU on March 5, 2020 depending on the level of achievement of certain targets. See “CD&A-Long-Term Incentive Program Granted in 2017 and 2018” above. The table reflects two shares per RSU based on the performance against the targets through December 29, 2017, the last day of trading for 2017.
|
|
(7)
|
See “—Narrative to Summary Compensation Table” regarding the vesting of Mr. Wooten's awards.
|
|
|
|
Stock Awards
|
||
|
Name
|
|
Number of Securities
Acquired on Vesting (#) |
|
Value Realized on Vesting
($) |
|
Jeffrey W. Eckel
|
|
66,381
|
|
1,417,234
|
|
J. Brendan Herron
|
|
14,572
|
|
311,112
|
|
Nathaniel J. Rose
|
|
10,929
|
|
233,334
|
|
Steven L. Chuslo
|
|
10,929
|
|
233,334
|
|
Daniel K. McMahon
|
|
10,929
|
|
233,334
|
|
M. Rhem Wooten Jr.
|
|
10,929
|
|
233,334
|
|
•
|
Chairman, Chief Executive Officer and President: six times base salary;
|
|
•
|
all other NEOs: three times base salary; and
|
|
•
|
all other directors: five times the cash retainer.
|
|
|
|
Shares of Common Stock Beneficially Owned
|
|||
|
Name
(1)
|
|
Number
|
|
Percent
(2)
|
|
|
Named Executive Officers and Directors:
|
|
|
|
|
|
|
Jeffrey W. Eckel
(3)
|
|
1,194,491
|
|
|
2.2%
|
|
J. Brendan Herron
(4)
|
|
362,720
|
|
|
*
|
|
Nathaniel J. Rose
(5)
|
|
279,307
|
|
|
*
|
|
Steven L. Chuslo
(6)
|
|
285,314
|
|
|
*
|
|
Daniel K. McMahon
|
|
241,795
|
|
|
*
|
|
M. Rhem Wooten Jr.
(7)
|
|
301,985
|
|
|
*
|
|
Rebecca B. Blalock
|
|
6,827
|
|
|
*
|
|
Teresa M. Brenner
|
|
10,360
|
|
|
*
|
|
Mark J. Cirilli
(8)
|
|
64,244
|
|
|
*
|
|
Charles M. O’Neil
|
|
24,645
|
|
|
*
|
|
Richard J. Osborne
|
|
32,145
|
|
|
*
|
|
Steven G. Osgood
|
|
23,281
|
|
|
*
|
|
All directors and executive officers as a group (12 persons)
|
|
2,827,114
|
|
|
5.3%
|
|
5% or Greater Beneficial Owners:
|
|
|
|
|
|
|
T. Rowe Price Associates, Inc.
(9)
|
|
4,720,196
|
|
|
8.9%
|
|
Wellington Management Group LLP
(10)
|
|
4,525,350
|
|
|
8.5%
|
|
Blackrock, Inc.
(11)
|
|
4,467,704
|
|
|
8.4%
|
|
*
|
Represents beneficial ownership of less than 1%.
|
|
(1)
|
The address for each of the directors and officers named above is 1906 Towne Centre Blvd, Suite 370, Annapolis, Maryland 21401.
|
|
(2)
|
As of April 5, 2018, there were a total of 53,550,283 shares of our Common Stock and OP units outstanding, which is comprised of 51,826,553 shares of Common Stock, 1,442,441 unvested shares of restricted Common Stock and 281,289 shares of Common Stock issuable upon redemption of OP units, which are or will be redeemable for cash or, at our option, exchangeable on a one-for-one basis into shares of our Common Stock. In addition, share amounts for all persons assume that all OP units held by the person are exchanged for shares of our Common Stock and that all unvested restricted stock vest. The total number of shares of Common Stock outstanding used in calculating this percentage assumes that none of the OP units held by other persons are exchanged for shares of our Common Stock. Does not include 413,704 restricted stock units that have been awarded but are not yet convertible within 60 days of above date into shares of Common Stock.
|
|
(3)
|
This amount includes 42,000 shares held by the individual’s significant other, 1,520 shares held by the individual's grandson and 588,881 shares held by the Jeffrey W. Eckel Revocable Trust of which Mr. Eckel is the sole trustee and beneficiary.
|
|
(4)
|
Consists of 226,782 shares of Common Stock (including unvested restricted Common Stock) and 135,938 OP units. The amount includes 6,920 shares held by the individual’s spouse and minor children.
|
|
(5)
|
This amount includes 10,000 shares held by the individual’s spouse.
|
|
(6)
|
This amount includes 4,700 shares held by the individual’s significant other.
|
|
(7)
|
This amount includes 29,345 shares held by the individual’s spouse.
|
|
(8)
|
Consists of 62,392 shares of Common Stock (including unvested restricted Common Stock) and 1,852 OP units.
|
|
(9)
|
Based on information provided in a Schedule 13G/A filed on February 14, 2018, T. Rowe Price Associates, Inc. reported sole voting power with respect to 1,171,736 shares of Common Stock beneficially owned by it and sole dispositive power with respect to 4,720,196 shares of Common Stock beneficially owned by it. The Schedule 13G/A reports beneficial ownership information, which does not include any shares acquired or sold since the date of such Schedule 13G/A. T. Rowe Price Associates, Inc.’s address is 100 E. Pratt Street, Baltimore, Maryland 21202.
|
|
(10)
|
Based on information provided in a Schedule 13G/A filed on February 8, 2018, Wellington Management Group LLP reported shared voting power with respect to 2,085,130 shares of Common Stock beneficially owned by it and shared dispositive power with respect to 4,525,350 shares of Common Stock beneficially owned by it. The Schedule 13G/A reports beneficial ownership information, which does not include any shares acquired or sold since the date of such Schedule 13G/A. The business address of Wellington Management Group LLP is 280 Congress Street, Boston, MA 02210.
|
|
(11)
|
Based on information provided in a Schedule 13G/A filed on January 25, 2018, BlackRock, Inc. reported sole voting power with respect to 4,342,448 shares of Common Stock beneficially owned by it and sole dispositive power with respect to 4,467,704 shares of Common Stock beneficially owned by it. The Schedule 13G/A reports beneficial ownership information, which does not include any shares acquired or sold since the date of such Schedule 13G/A. BlackRock, Inc.’s address is 55 East 52nd Street, New York, New York 10055.
|
|
By Order of the Board,
|
|
|
|
/s/ Jeffrey W. Eckel
|
|
Jeffrey W. Eckel
|
|
President and Chief Executive Officer
|
|
IMPORTANT NOTICE OF AVAILABILITY OF PROXY MATERIAL FOR THE ANNUAL MEETING:
|
|
1.
|
The election as directors of all of the Nominees or the individual nominees listed below:
|
FOR
|
WITHOLD
|
|
|
|
|
ALL NOMINEES
|
☐
|
☐
|
|
|
|
|
Jeffrey W. Eckel
|
☐
|
☐
|
|
|
|
|
Rebecca B. Blalock
|
☐
|
☐
|
|
|
|
|
Teresa M. Brenner
|
☐
|
☐
|
|
|
|
|
Mark J. Cirilli
|
☐
|
☐
|
|
|
|
|
Charles M. O’Neil
|
☐
|
☐
|
|
|
|
|
Richard J. Osborne
|
☐
|
☐
|
|
|
|
|
Steven G. Osgood
|
☐
|
☐
|
|
|
|
|
|
FOR
|
AGAINST
|
ABSTAIN
|
|
|
2.
|
The ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018.
|
☐
|
☐
|
☐
|
|
|
3.
|
The advisory approval of the compensation of the Named Executive Officers as described in the Compensation Discussion and Analysis, the compensation tables and other narrative disclosure in this Proxy Statement.
|
☐
|
☐
|
☐
|
|
|
4.
|
The transaction of any other business that may properly come before the meeting or any adjournment thereof.
|
|
|
|
|
|
The undersigned acknowledges receipt from the Company before the execution of this proxy of the Notice of Annual Meeting of Stockholders and a Proxy Statement for the Annual Meeting of Stockholders, the terms of which are incorporated herein by reference, and the 2017 Annual Report to Stockholders.
|
|||||
|
If this Proxy is properly executed, the votes entitled to be cast by the undersigned will be cast (i) as directed or, if no direction is given, will be cast “FOR” the election of all of the nominees listed herein and “FOR” items 2 and 3, and (ii) in the discretion of the Proxy holders on any other business that may properly come before the meeting or any adjournment or postponement thereof.
|
|||||
|
|
I plan to attend the Annual Meeting
|
|
|
|
☐
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
To change the address on your account, please check the box at the right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the account may not be submitted via this method.
|
☐
|
|||
|
Signature of Stockholder
|
|
Date:
|
|
Signature of Stockholder
|
|
Date:
|
|
|
Note:
|
Please sign exactly as your name or names appear on this Proxy and date. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.
|
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|